16006-64-7
Chemical Structure
9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine
- CAS No.: 16006-64-7
- Formula:C12H15N3O3
- Molecular Weight:249.27
IUPAC Name: (2R,3S,5R)-2-(hydroxymethyl)-5-(4-methyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydrofuran-3-ol
InChIKey: CJTVGDOEAJKEPM-HBNTYKKESA-N
SMILES: O[C@H]1C[C@H](N2C=CC3=C2N=CN=C3C)O[C@@H]1CO
Biological Activity: (2R,3S,5R)-2-(hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3-ol (9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine | 95.0% | (2R,3S,5R)-2-(hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3-ol (9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
